Circio logoCircio logo

  • About
      • About Circio
      • CEO Statement
      • Pipeline
      • Management Team
      • Board of Directors
      • Careers
      • The Norwegian Transparency Act
  • circRNA
      • Circio AB
      • circVec platform
  • Clinical programs
      • KRAS program
      • Publications
  • Partnering
  • Investors
      • Press releases
      • Events
      • Financial calendar
      • Reports
      • Presentations
      • Prospectus
      • Share facts
      • Largest shareholders
      • Dividend policy
      • Analyst coverage
      • Registrar and auditor
      • Corporate Governance Policy
      • Code of Conduct
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
        • General Meetings
      • Articles of Association
      • Board of Directors
        • Nomination Committee
        • Committees
      • Management
      • Contact
  • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
  • Contacts
    • About
      • About Circio
      • CEO Statement
      • Our pipeline
      • Management Team
      • Board of Directors
      • Careers
      • The Norwegian Transparency Act
    • circRNA
      • Circio AB
      • circVec platform
    • Clinical programs
      • KRAS program
      • Publications
    • Partnering
      • Partnering
    • Investors
      • Warrants exercise 2024
      • Press releases
      • Events
      • Financial calendar
      • Reports
      • Presentations
      • Prospectus
      • Share information
        • Share and trading information
        • Largest shareholders
        • Dividend policy
        • Analyst coverage
        • Registrar and auditor
      • Corporate Governance Policy
      • Code of Conduct
      • Corporate Social Responsibility Principles
      • Remuneration Principles
      • About General Meeting
      • General Meetings
      • Articles of Association
      • Board of Directors
      • Nomination Committee
      • Committees
      • Management
      • Contact
    • Media
      • Press releases
      • Events
      • Subscribe
      • Contact
    • Contacts
      • Offices
      • Investors & Media
    All press releases
    • Press releases - Regulatory
    • Press releases - Non-regulatory
    • All press releases
    2025
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    All subjects
    • Corporate news
    • Other
    All languages
    • English
    • Norwegian
    December 8, 2025
    Press release - Regulatory

    Circio Holding ASA – Key information related to the rights issue

    December 8, 2025
    Press release - Regulatory

    Circio announces 88% underwritten and presubscribed NOK 50 million rights issue with strong support from existing shareholders

    November 24, 2025
    Press release - Regulatory

    Circio presents data that further strengthens and broadens its circVec circular RNA expression platform

    November 18, 2025
    Press release - Regulatory

    Circio enters fully funded feasibility study with major global pharmaceutical corporation

    November 17, 2025
    Press release - Non-regulatory

    Circio issues invitation to R&D and corporate update webcast on 24 November 2025

    October 23, 2025
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    October 22, 2025
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    October 20, 2025
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    October 19, 2025
    Press release - Regulatory

    Circio Holding ASA – Bond conversion and additional trading restrictions

    October 17, 2025
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    October 15, 2025
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    October 8, 2025
    Press release - Regulatory

    Circio presents comprehensive circVec in vivo data package demonstrating 40-fold improvement over conventional AAV gene delivery at ESGCT 2025

    October 6, 2025
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    October 1, 2025
    Press release - Regulatory

    Circio Holding ASA – Approval and publication of prospectus for potential future share issues and conversion of convertible bonds

    October 1, 2025
    Press release - Regulatory

    Circio to present comprehensive circVec-AAV in vivo data package at ESGCT 2025

    September 9, 2025
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    September 5, 2025
    Press release - Regulatory

    Circio Holding ASA – Conversion of Convertible Bonds and funding requested under Additional Financing Commitment from Atlas

    August 28, 2025
    Press release - Regulatory

    Circio presents new circVec-AAV vectors showing up to 40x enhanced activity in first half year report webcast

    August 21, 2025
    Press release - Non-regulatory

    Circio invites to first half 2025 report and R&D update webcast on 28 August

    August 4, 2025
    Press release - Regulatory

    Circio Holding ASA – Funding requested under additional financing commitment from Atlas

    July 7, 2025
    Press release - Non-regulatory

    Circio expanding its R&D operations in Stockholm to accelerate circVec development

    July 4, 2025
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    June 30, 2025
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    June 30, 2025
    Press release - Regulatory

    NeoRegen Biotech and Circio advance circular RNA delivery collaboration into in vivo stage

    June 20, 2025
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    June 17, 2025
    Press release - Regulatory

    Circio Holding ASA – Funding requested under financing commitment from Atlas

    June 17, 2025
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    June 16, 2025
    Press release - Non-regulatory

    TG01 mutant RAS cancer vaccine data showing clinical benefit in multiple myeloma presented at EHA 2025

    June 6, 2025
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    June 5, 2025
    Press release - Regulatory

    Circio Holding ASA: Minutes from the annual general meeting 2025

    June 4, 2025
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    May 28, 2025
    Press release - Regulatory

    Circio presents new and differentiating circVec data and corporate update in live webcast

    May 27, 2025
    Press release - Regulatory

    Circio Holding ASA – Updated information to the notice of annual general meeting 2025 – Reverse share split and share capital decrease

    May 22, 2025
    Press release - Non-regulatory

    Circio invites to R&D and corporate update webcast on 28 May 2025

    May 15, 2025
    Press release - Regulatory

    Circio Holding ASA – Notice of annual general meeting 2025

    May 15, 2025
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    May 13, 2025
    Press release - Regulatory

    Circular RNA innovator Circio presents strengthened circVec gene therapy data at ASGCT 2025

    May 13, 2025
    Press release - Regulatory

    Circio Holding ASA – Funding requested under financing commitment from Atlas

    May 13, 2025
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    May 7, 2025
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    May 6, 2025
    Press release - Non-regulatory

    Circular RNA innovator Circio to present strengthened circVec gene therapy data at ASGCT 2025

    May 5, 2025
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    April 30, 2025
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    April 28, 2025
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    April 16, 2025
    Press release - Regulatory

    Circio Holding ASA – Funding requested under financing commitment from Atlas

    April 14, 2025
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    April 11, 2025
    Press release - Regulatory

    Circio Holding ASA: Annual Report 2024 – Correction to ESEF-file name

    April 11, 2025
    Press release - Regulatory

    Circio Holding ASA: Annual Report 2024

    April 11, 2025
    Press release - Non-regulatory

    Circio signs research license with Lonza

    April 10, 2025
    Press release - Regulatory

    Circio Holding ASA: Annual Report 2024

    April 10, 2025
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    April 3, 2025
    Press release - Non-regulatory

    Entos Pharmaceuticals and Circio initiate collaboration to test novel platform for circVec circular RNA delivery

    March 26, 2025
    Press release - Regulatory

    Circio presents R&D and corporate update in live webcast

    March 19, 2025
    Press release - Regulatory

    Circio invites to corporate update webcast on 26 March 2025

    March 14, 2025
    Press release - Regulatory

    Circio Holding ASA – Funding requested under financing commitment from Atlas

    March 5, 2025
    Press release - Regulatory

    Circio presents results that further validate the circVec circular RNA platform at two international industry conferences

    March 3, 2025
    Press release - Non-regulatory

    Circio´s leading position in circular RNA therapeutics highlighted by continued broad coverage in international life science industry media

    February 26, 2025
    Press release - Non-regulatory

    Circio invited to present advantages of circVec circular RNA technology at international industry conferences

    January 21, 2025
    Press release - Non-regulatory

    4basebio partners with Circio to build and test circVec synthetic DNA vectors for genetic medicine and vaccines

    January 16, 2025
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    January 14, 2025
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    January 13, 2025
    Press release - Non-regulatory

    Circio publishes wide-ranging review on potential of circular RNA therapeutics in Nature Reviews Genetics

    January 9, 2025
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

    January 6, 2025
    Press release - Regulatory

    Circio Holding ASA: Requested Conversion of Convertible Bonds

    January 6, 2025
    Press release - Regulatory

    Circio Holding ASA: Registration of share capital increase following warrant exercise and private placement

    IR contact
    Dr Erik Digman Wiklund
    Dr Erik Digman Wiklund
    CEO
    erik.wiklund@circio.com
    (+47) 41 33 35 36
    Dr Lubor Gaal
    Dr Lubor Gaal
    CFO & Head of BD
    lubor.gaal@circio.com
    (+34) 683 343 811
    Circio logo

    Circio Holding ASA is a biotechnology company developing novel circular RNA and immunotherapy medicines.

    • About
    • circRNA
    • Clinical programs
    • Partnering
    • Investors
    • Media
    • Contacts

    CONTACT

    Circio Holding ASA
    Email: contact@circio.com

    • Cookies
    • Privacy policy
    • STAY CONNECTED